期刊文献+

2547株肠球菌分布特征及耐药谱变迁 被引量:4

distribution and drug resistance of 2547 enterococci strains
原文传递
导出
摘要 目的 探讨肠球菌属的分布特征及耐药性变迁,为临床治疗提供参考.方法 回顾性分析2001至2007年湖州市中心医院和湖州市第一人民医院各类临床标本中分离出的肠球菌属的分布特点、检出率及药物敏感性.结果 94876份临床标本中检出肠球菌2547株(2.68%),其中粪肠球菌为主要菌种,屎肠球菌次之.肠球菌属在各种临床标本中的分布仍以尿液为主,痰液标本中肠球菌属的比例逐年增加.肠球菌属对红霉素、利福平、环丙沙星和左氧氟沙星具有较高的耐药性.粪肠球菌对青霉素、氨苄西林和呋喃妥因敏感性较好;屎肠球菌的耐药率逐年上升,但对四环素和氯霉素的耐药率低于粪肠球菌.肠球菌属对万古霉素和替考拉宁仍然保持很高的敏感性.结论 肠球菌属感染以粪肠球菌和屎肠球菌为主,由其引起的呼吸道感染在增加.肠球菌届的总体耐药率较高,临床上应根据药物敏感性试验结果选择敏感的抗菌药物治疗.abstract:objective to investigate the characteristics of distribution and the changes in drug resistance of enterococci,providing reference for clinical treatment.methods the distribution and drug resistance in 2547 clinical isolates of enterococci from 2001 to 2007 in huzhou central hospital and the first people's hospital of huzhou were retrospectively analyzed.results a total of 2547 strains of enterococci were isolated from 94876 clinical specimens(2.68%),in which enterococcus faecalis wag primary and enterococcus faecium wag ranking the second.the positive rate of enterococci in urine specimens was the highest,and that in sputum specimens was increasing recently.enterococci showed higg resistance to erythromycin,rifampin,ciprofloxacin and levofloxacin;enterococcus faecalis wag more sensitive to penicillin,ampiciilin and ndtrofurantoin than enterococcus faecium,while euterococcus faecium was more sensitive to chloramphended and tetracycline than enterococcus faecalis;both of them were s
出处 《中华临床感染病杂志》 CAS 2008年第3期-,共3页 Chinese Journal of Clinical Infectious Diseases
  • 相关文献

同被引文献23

  • 1童照威,王伟洪,施柏年.常见葡萄球菌感染及耐药分析[J].中国实用内科杂志,2005,25(9):810-811. 被引量:7
  • 2王艳,高灵宝,徐祖龙.临床革兰阴性菌的分布及耐药性变迁[J].中国医院药学杂志,2006,26(3):343-344. 被引量:6
  • 3Gander S,Haywark K,Finch R.An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro phammcokinetic model.J Antimicrob Chemother,2002,49(2):301-308. 被引量:1
  • 4Wilcox M,Nathwani D,Dryden M.Linezolid compared with teicoplanin for the treatment of suspected Or proven Gram-positive infections.J Antimicreb Chemother,2004,53(2):335-344. 被引量:1
  • 5Moise PA,Forrest A,Birmingham MC,et al.The efficacy and safety oflinezolid as treatment for Staphylococcus aureus infections in compassionate n6e patients who are intolerant of,or who have failed to respond to,vancomyein.J Antimierob Chemother,2002,50(6):1017-1026. 被引量:1
  • 6De Cock E,Soronsen S,Levrat F,et al.Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.Med Mal Infect,2009,39(5):330-340. 被引量:1
  • 7De Cock E,KruegecWA,Sorensen S,et al.Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosecomial pneumonia in Germany.Infection,2009,37(2):123-132. 被引量:1
  • 8Shorr AF,Krmkel MJ,Kollef M.Linezolid versus vancomycin for Staphylococcus aureus bacteraemia:pooled analysis of randomized studies.J Antimicrob Chemother,2005,56(5):923-929. 被引量:1
  • 9Wilcox MH,Tack KJ,Bouza E,et al.Complicated skin and skinstructure infections and catheter-related bloodstream infections:noninferiority of linezolid in a phase 3 study.Clin Infect Dis,2009,48(2):203-212. 被引量:1
  • 10Carsonti-Dellamoniea H,Galimand M,Vandenbos F,et al.In vitro selection of mutants of Streptococcus pneumoniae resistant to macmlides and linemlid:relationship with susceptibility to penicillin G or macrolides.J Antimicrob Chemother,2005,56(4):633-642. 被引量:1

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部